首页> 外文期刊>JAMA: the Journal of the American Medical Association >Progress in the Adjuvant Treatment of Colon Cancer Has It Influenced Clinical Practice?
【24h】

Progress in the Adjuvant Treatment of Colon Cancer Has It Influenced Clinical Practice?

机译:结肠癌辅助治疗的进展是否影响了临床实践?

获取原文
获取原文并翻译 | 示例
       

摘要

Among patients with colon cancer, 70% present with apparently localized disease. In these patients, surgery can be curative, but relapses after complete resection are frequent. Colon cancer is not uniformly fatal and there are large differences in survival depending on the stage of the disease at diagnosis. The pathological stage is currently the most important determinant of prognosis. The classification system described by Dukes in 1930 is still widely used, but it no longer fulfills the requirements of modern tumor staging because it does not take into account distant metastases, number of lymph nodes involved, and carcinomas limited to the submucosa. Therefore, the TNM classification of the American Joint Committee on Cancer (AJCC) is recommended both for daily clinical practice and for clinical trials. The AJCC Cancer Staging Manual is now used to stage colon cancer and all other cancers, and the latest edition stratifies colon cancer stages II and III further by use of T stage (ie, tumor depth ofpenetration) and N stage.
机译:在结肠癌患者中,有70%患有明显的局部疾病。在这些患者中,手术是可以治愈的,但是完全切除后复发是很常见的。结肠癌并非一律致命,并且根据诊断时疾病的阶段,生存率存在很大差异。病理阶段是目前最重要的预后决定因素。 Dukes在1930年描述的分类系统仍被广泛使用,但由于它没有考虑远处转移,所累及的淋巴结数目和局限于粘膜下层的癌,因此不再满足现代肿瘤分期的要求。因此,建议将美国癌症联合委员会(AJCC)的TNM分类用于日常临床实践和临床试验。 AJCC癌症分期手册现已用于分期结肠癌和所有其他癌症,最新版本通过使用T期(即肿瘤穿透深度)和N期进一步对II期和III期结肠癌进行分层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号